Menlo Advisors LLC Abb Vie Inc. Transaction History

Menlo Advisors LLC

$194 Million
Q3 2024

A detailed history of Menlo Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Menlo Advisors LLC holds 38,902 shares of ABBV stock, worth $6.97 Million. This represents 3.95% of its overall portfolio holdings.

Number of Shares

38,902

Previous 38,902 -0.0%

Holding current value

$6.97 Million

Previous $6.67 Million 15.14%

% of portfolio

3.95%

Previous 3.7%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $30,958 - $36,152	-200 Reduced 0.51%	38,902 $6.67 Million
Q1 2024 Apr 19, 2024	BUY	$159.82 - $182.1 $228,542 - $260,403	1,430 Added 3.8%	39,102 $7.12 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $43,728 - $54,417	-330 Reduced 0.87%	37,672 $5.08 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $86,565 - $99,284	-645 Reduced 1.67%	38,002 $5.1 Million
Q4 2021 Feb 16, 2022	SELL	$107.43 - $135.93 $100,984 - $127,774	-940 Reduced 2.37%	38,647 $5.23 Million
Q2 2021 Aug 30, 2021	SELL	$105.21 - $117.21 $48,396 - $53,916	-460 Reduced 1.15%	39,587 $4.46 Million
Q1 2021 Apr 13, 2021	SELL	$102.3 - $112.62 $204,600 - $225,240	-2,000 Reduced 4.76%	40,047 $4.33 Million
Q2 2020 Jul 17, 2020	SELL	$73.37 - $98.18 $5,135 - $6,872	-70 Reduced 0.17%	42,047 $4.13 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $96,427 - $146,196	-1,495 Reduced 3.43%	42,117 $3.21 Million
Q3 2019 Oct 08, 2019	SELL	$62.98 - $75.72 $9,447 - $11,358	-150 Reduced 0.34%	43,612 $3.3 Million
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $5,978 - $7,642	-91 Reduced 0.21%	43,762 $3.18 Million
Q1 2019 Apr 10, 2019	SELL	$77.14 - $90.79 $45,512 - $53,566	-590 Reduced 1.33%	43,853 $3.53 Million
Q4 2018 Jan 09, 2019	SELL	$77.85 - $96.01 $341,917 - $421,675	-4,392 Reduced 8.99%	44,443 $4.1 Million
Q1 2018 Apr 11, 2018	SELL	$92.01 - $123.21 $1.96 Million - $2.63 Million	-21,350 Reduced 30.42%	48,835 $4.62 Million
Q4 2017 Jan 09, 2018	SELL	$89.56 - $98.21 $138,638 - $152,029	-1,548 Reduced 2.16%	70,185 $6.79 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $5.01 Million - $6.4 Million	71,733	71,733 $6.37 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Menlo Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menlo Advisors LLC with notifications on news.

Account

Menlo Advisors LLC Abb Vie Inc. Transaction History